|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4741 | |
| A61K 38/17 | |||
| A61K 45/00 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3229803 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15816534.0 |
| Europos patento paraiškos padavimo data | 2015-12-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/059525 |
| Data | 2015-12-10 |
| (87) | Numeris | WO 2016/092508 |
| Data | 2016-06-16 |
| (30) | Numeris | Data | Šalis |
| 201462091200 P | 2014-12-12 | US |
| (72) |
SHENG, Qing, US
JAIN, Rakesh K., US
ASKOXYLAKIS, Vasileios, US
FERRARO, Gino B., US
FUKUMURA, Dai, US
KODACK, David P., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, US |
| (54) | TREATMENT OF BREAST CANCER BRAIN METASTASES |
| TREATMENT OF BREAST CANCER BRAIN METASTASES |